Skip to main content
Equibles

GUD · Knight Therapeutics Inc.

Use GUD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GUD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
11.5600 CAD +0.2600 (+2.30%) At close · Nov 5 Intraday price with Plus
Rebalance outlook locked
Market Cap
1.14B CAD
Shares
98.23M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close11.5600 CAD Open11.8400 CAD Day11.2900–11.8600 CAD 52W close5.7600–11.7000 CAD Avg vol 30d65K Last earningsNov 5, 2026 DataJan 2020–Nov 2026

Latest documents

2026
Nov 5
Report SEDAR+
MD&A
All documents

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 5.7600 CAD Now 11.5600 CAD · 98% Range high 11.7000 CAD
vs 200-day avg +34% vs 50-day avg +10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XTSE:GUD +1.4% +7.9% +33.8% +2.6% +91.1%

Exchange listing

Market
XTSE
Ticker
GUD
ISIN
—
Security
Ordinary share
Trading currency
CAD

Company

Website
https://www.knighttx.com/
Investor relations
https://investors.knighttx.com/

Other listings of this company

No other verified listings are available.

Latest price

Plus & Pro

Follow GUD during the session: the latest price, the day's change, range and volume. Closing prices stay free.

View plans Sign in

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q3 2026 2026-11-05 Audio Transcript
    Knight Therapeutics' Third Quarter 2026 Results Conference Call
  • Earnings call · Q2 2026 2026-08-06
    Knight Therapeutics Reports Second Quarter 2026 Results
  • Earnings call · Q1 2026 2026-05-07
    Knight Therapeutics Reports First Quarter 2026 Results
  • Earnings call · Q4 2025 2026-03-19
    Knight Therapeutics Reports Fourth Quarter and Year-End 2025 Results